Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     

NANOPHASE TECHNOLOGIES CORPORATION

(NANX)
Delayed OTC Markets  -  12:44 2022-11-25 pm EST
1.400 USD    0.00%
11/18Insider Buy: Nanophase Technologies
MT
11/14NANOPHASE TECHNOLOGIES CORP Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)
AQ
11/09Transcript : Nanophase Technologies Corporation, Q3 2022 Earnings Call, Nov 09, 2022
CI
SummaryQuotesChartsNewsCalendarCompanyFinancialsFunds 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

SolÚsence Beauty Science to Exhibit Cosmetics Infused with SPF at MakeUp In New York

09/13/2022 | 04:01pm EST

ROMEOVILLE, Ill., Sept. 13, 2022 (GLOBE NEWSWIRE) -- Nanophase Technologies Corporation (OTCQB: NANX), a leader in minerals-based and scientifically-driven health care solutions across beauty and life science categories — with innovations that protect skin from environmental aggressors and aid in medical diagnostics — today announced that Solésence Beauty Science will be exhibiting at MakeUp in New York on September 14th and 15th, 2022.

MakeUp in New York is “a professional and convivial event connecting the most innovative and talented cosmetic suppliers with the most successful skincare and make-up brands,” according to the event website. Solésence Beauty Science, a leader in inclusive, mineral-based beauty products for skincare and makeup brands, will be exhibiting at MakeUp in New York for the first time. Solésence will showcase its market-ready products that embrace self-expression, health care, and self-care, blurring skin care with color cosmetics while providing best-in-class UV and environmental protection. Their award-winning formula, Multi-Cultural Magic SPF 50+ featuring Kleair™, will be at the show.

The announcement comes on the heels of Solésence being shortlisted as a finalist for Best Contract Manufacturer in the BeautyMatter NEXT Awards.

“We are thrilled to join other industry leaders across makeup and skincare categories at MakeUp in New York. We chose to participate on a last-minute basis in response to requests from both current and prospective brand partners. Coupled with the increased interest in SPF-infused beauty products across the industry, we are expecting a busy show. We look forward to seeing familiar faces as well as making the acquaintance of some new ones,” commented Kevin Cureton, Chief Operating Officer.

About Solésence Beauty Science
Solésence, LLC, www.solesence.com, a wholly owned subsidiary of Nanophase Technologies, is changing the face of skin health with patented, mineral-based technology that is embraced by leading performance-driven and clean beauty brands alike. Our patented products for brands transform the way mineral actives look, feel and function — enabling textures never-before-seen in the mineral space and inclusivity never-before-seen in the sun care space. Solésence’s innovative formulations offer best-in-class UV protection, unparalleled free radical prevention to protect against pollution, and enhanced antioxidant performance.

About Nanophase Technologies
Nanophase Technologies Corporation (OTCQB: NANX), www.nanophase.com, is a leading innovator in minerals-based and scientifically driven health care solutions across beauty and life science categories, as well as other legacy advanced materials applications. Leveraging a platform of integrated, patented, and proprietary technologies, the Company creates products with unique performance, enhancing consumers' health and wellbeing. We deliver commercial quantity and quality engineered materials both as ingredients and as part of fully formulated products in a variety of formats.

Forward-Looking Statements
This press release contains words such as “expects,” shall,” “will,” “believes,” and similar expressions that are intended to identify forward-looking statements within the meaning of the Safe Harbor Provisions of the Private Securities Litigation Reform Act of 1995. Such statements in this announcement are made based on the Company’s current beliefs, known events and circumstances at the time of publication, and as such, are subject in the future to unforeseen risks and uncertainties that could cause the Company’s results of operations, performance, and achievements to differ materially from current expectations expressed in, or implied by, these forward-looking statements. These risks and uncertainties include, without limitation, the following: a decision by a customer to cancel a purchase order or supply agreement in light of the Company’s dependence on a limited number of key customers; uncertain demand for, and acceptance of, the Company’s engineered materials, ingredients, and fully formulated products; the Company’s manufacturing capacity and product mix flexibility in light of customer demand; the Company’s limited marketing experience; changes in development and distribution relationships; the impact of competitive products and technologies; the Company’s dependence on patents and protection of proprietary information; the resolution of litigation in which the Company may become involved; the impact of any potential new government regulations that could be difficult to respond to or too costly to comply with while remaining financially viable; the ability of the Company to maintain an appropriate electronic trading venue; and other factors described in the Company’s Form 10-K filed March 31, 2022. In addition, the Company’s forward-looking statements could be affected by general industry and market conditions and growth rates. Except as required by federal securities laws, the Company undertakes no obligation to update or revise these forward-looking statements to reflect new events, uncertainties, or other contingencies.

Media Contact:
Emma Harper
Email: eharper@solesence.com
Phone: (630) 686-1574

Investor Relations Contact:
Phone: (630) 771-6736


Primary Logo

Source: Nanophase Technologies Corporation

2022 GlobeNewswire, Inc., source Press Releases

All news about NANOPHASE TECHNOLOGIES CORPORATION
11/18Insider Buy: Nanophase Technologies
MT
11/14NANOPHASE TECHNOLOGIES CORP Management's Discussion and Analysis of Financial Conditio..
AQ
11/09Transcript : Nanophase Technologies Corporation, Q3 2022 Earnings Call, Nov 0..
CI
11/08Earnings Flash (NANX) NANOPHASE TECHNOLOGIES CORPORATION Posts Q3 Revenue $9.7M
MT
11/08Nanophase Reports Strong Revenue for Third Quarter as Growth Continues
AQ
11/08Nanophase Technologies Corporation Reports Earnings Results for the Third Quarter and N..
CI
11/01Nanophase Technologies Announces Third Quarter 2022 Financial Release and Conference Ca..
GL
09/29Kleair™ Technology Announced Best in Sun/Light Protection Category at Cosmetics &..
AQ
09/23Solésence Beauty Science Returns to Beauty Biz Roundtable for Third Year
AQ
09/13Solésence Beauty Science to Exhibit Cosmetics Infused with SPF at MakeUp In New York
AQ
More news
Financials (USD)
Sales 2021 29,5 M - -
Net income 2021 2,32 M - -
Net Debt 2021 14,1 M - -
P/E ratio 2021 88,0x
Yield 2021 -
Capitalization 68,8 M 68,8 M -
EV / Sales 2020 2,28x
EV / Sales 2021 7,75x
Nbr of Employees 58
Free-Float 30,6%
Chart NANOPHASE TECHNOLOGIES CORPORATION
Duration : Period :
Nanophase Technologies Corporation Technical Analysis Chart | MarketScreener
Full-screen chart
Income Statement Evolution
Managers and Directors
Jess A. Jankowski President, Chief Executive & Financial Officer
Rebecca Janet Whitmore Chairman
H. Glenn Judd Vice President-Engineering
Harry W. Sarkas Vice President-Research & Development
Kevin Cureton Chief Operating Officer
Sector and Competitors
1st jan.Capi. (M$)
NANOPHASE TECHNOLOGIES CORPORATION-68.18%69
ECOLAB INC.-36.03%42 425
SIKA AG-35.19%39 724
ALBEMARLE CORPORATION16.70%31 962
GIVAUDAN SA-32.14%31 695
EMS-CHEMIE HOLDING AG-34.77%16 521